AKT1 and cancer: Significantly downregulated pathways found with KITLG were hematopoietic cell lineage, melanogenesis, Rap1 signaling, mitogen-activated protein kinase (MAPK) signaling, P13/AKT signaling, pathways in cancer, PLD signaling, and Ras signaling.